Human SLC2A1 Full Length Protein, His Tag (Detergent)

사용자 리뷰
제품 번호/규격
가격
수량
SL1-H55H3-20ug
$805.00
SL1-H55H3-100ug
$2985.00
SL1-H55H3-500ug
$7480.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    CSE, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT-1, GLUT1, GLUT1DS, HTLVR, PED, SDCHCN

  • Source

    Detergent Human SLC2A1 Full Length Protein, His Tag (SL1-H55H3) is expressed from Baculovirus-Insect cells. It contains AA Glu 2 - Val 492 (Accession # P11166).

    Predicted N-terminus: Glu 2

    Request for sequence
  • Molecular Characterization

    SLC2A1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 56.0 kDa. The protein migrates as 43-45 kDa and 55-80 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM Nacl, DDM, pH7.5, CHS with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    SLC2A1 SDS-PAGE

    Human SLC2A1 Full Length Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     SLC2A1 ELISA

    Immobilized Human SLC2A1 Full Length Protein, His Tag (Cat. No. SL1-H55H3) at 1 μg/mL (100 μL/well) on a Nickel Coated plate can bind Anti-SLC2A1 Antibody with a linear range of 0.2-16 ng/mL (QC tested).

    Protocol
  • Bioactivity-BLI

     SLC2A1 BLI

    Loaded Anti-SLC2A1 Antibody on AMC Biosensor, can bind Human SLC2A1 Full Length Protein, His Tag (Cat. No. SL1-H55H3) with an affinity constant of 29.3 nM as determined in BLI assay (ForteBio Octet R8) (Routinely tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

SLC2A1 encodes GLUT1, a facilitative glucose transporter responsible for basal glucose uptake across the blood-brain barrier and into erythrocytes. It is essential for cerebral energy metabolism. Haploinsufficiency causes GLUT1 Deficiency Syndrome (early-onset epilepsy), while upregulated expression in cancer supports the Warburg effect, making it a metabolic oncology target.

프론티어 진행

 
연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호